Pages that link to "Q56961920"
Jump to navigation
Jump to search
The following pages link to Immune control of HIV-1 after early treatment of acute infection (Q56961920):
Displaying 50 items.
- Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention (Q21245029) (← links)
- HIV infection: first battle decides the war (Q22252422) (← links)
- Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults (Q24245709) (← links)
- Acute meningoencephalitis and meningitis due to primary HIV infection (Q24527228) (← links)
- Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection (Q24536249) (← links)
- Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection (Q24682861) (← links)
- Reconsidering early HIV treatment and supervised treatment interruptions (Q24796745) (← links)
- CD8 T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjects (Q24798701) (← links)
- Limited durability of viral control following treated acute HIV infection (Q24804986) (← links)
- The HIV vaccine saga (Q24805100) (← links)
- Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy (Q24815428) (← links)
- Should We Treat Acute HIV Infection? (Q26826523) (← links)
- Developing Combined HIV Vaccine Strategies for a Functional Cure (Q26998898) (← links)
- HIV therapeutic vaccines: moving towards a functional cure (Q27002180) (← links)
- Treatment with IL-7 prevents the decline of circulating CD4 T cells during the acute phase of SIV infection in rhesus macaques (Q27346577) (← links)
- Full-breadth analysis of CD8 T-cell responses in acute hepatitis C virus infection and early therapy (Q27472170) (← links)
- Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses (Q27472844) (← links)
- Interleukin-10 determines viral clearance or persistence in vivo (Q27486832) (← links)
- Immunopathogenesis and immunotherapy in AIDS virus infections (Q28183667) (← links)
- HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family (Q28214202) (← links)
- Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis (Q28243702) (← links)
- Selective regulation of human immunodeficiency virus-infected CD4( ) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice (Q28343440) (← links)
- Immunotherapy with canarypox vaccine and interleukin-2 for HIV-1 infection: termination of a randomized trial (Q28469122) (← links)
- Integrated analysis of residue coevolution and protein structures capture key protein sectors in HIV-1 proteins (Q28543396) (← links)
- DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus (Q28554534) (← links)
- Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption (Q28742727) (← links)
- Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection (Q28748901) (← links)
- Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies (Q29619015) (← links)
- Barriers to HIV Cure (Q30245414) (← links)
- Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials. (Q30328005) (← links)
- Prospects for an AIDS vaccine: three big questions, no easy answers. (Q30342038) (← links)
- HIVed, a knowledgebase for differentially expressed human genes and proteins during HIV infection, replication and latency (Q30400491) (← links)
- The role of observational data in monitoring trends in antiretroviral treatment and HIV disease stage: results from the Australian HIV observational database (Q30771406) (← links)
- Estimating the effect of antiretroviral treatment during HIV seroconversion: impact of confounding in observational data (Q30881515) (← links)
- Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection (Q30982732) (← links)
- Using engineering control principles to inform the design of adaptive interventions: a conceptual introduction (Q33266632) (← links)
- Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8 T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity (Q33327757) (← links)
- Resisting immune exhaustion in HIV-1 infection. (Q33332291) (← links)
- In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection (Q33402486) (← links)
- Modelling HIV immune response and validation with clinical data (Q33460449) (← links)
- Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy (Q33511372) (← links)
- Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful (Q33574329) (← links)
- The detection and management of early HIV infection: a clinical and public health emergency (Q33586581) (← links)
- Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection (Q33589386) (← links)
- Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit (Q33698152) (← links)
- Similar impact of CD8 T cell responses on early virus dynamics during SIV infections of rhesus macaques and sooty mangabeys (Q33701593) (← links)
- Vaccine-elicited memory cytotoxic T lymphocytes contribute to Mamu-A*01-associated control of simian/human immunodeficiency virus 89.6P replication in rhesus monkeys (Q33724322) (← links)
- HIV-1-specific CD4 T lymphocyte turnover and activation increase upon viral rebound (Q33731771) (← links)
- Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapy (Q33737646) (← links)
- Enhanced cellular immunity in macaques following a novel peptide immunotherapy (Q33737787) (← links)